{"id":348132,"date":"2025-08-25T13:58:47","date_gmt":"2025-08-25T13:58:47","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-cardiol-therapeutics\/"},"modified":"2025-08-25T13:58:47","modified_gmt":"2025-08-25T13:58:47","slug":"how-to-buy-cardiol-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o y h\u1ecdc tim m\u1ea1ch ti\u00ean ti\u1ebfn? Cardiol Therapeutics Inc. (CRDL) \u0111\u1ea1i di\u1ec7n cho bi\u00ean gi\u1edbi th\u00fa v\u1ecb c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u2014 n\u01a1i c\u00e1c \u0111\u1ed9t ph\u00e1 khoa h\u1ecdc c\u00f3 th\u1ec3 chuy\u1ec3n h\u00f3a th\u00e0nh l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1ch m\u1ea1ng cho c\u00e1c b\u1ec7nh tim \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n th\u1ebf gi\u1edbi. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a c\u00e2u chuy\u1ec7n \u0111\u1ed5i m\u1edbi y h\u1ecdc n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o y h\u1ecdc tim m\u1ea1ch ti\u00ean ti\u1ebfn? Cardiol Therapeutics Inc. (CRDL) \u0111\u1ea1i di\u1ec7n cho bi\u00ean gi\u1edbi th\u00fa v\u1ecb c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u2014 n\u01a1i c\u00e1c \u0111\u1ed9t ph\u00e1 khoa h\u1ecdc c\u00f3 th\u1ec3 chuy\u1ec3n h\u00f3a th\u00e0nh l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1ch m\u1ea1ng cho c\u00e1c b\u1ec7nh tim \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n th\u1ebf gi\u1edbi. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a c\u00e2u chuy\u1ec7n \u0111\u1ed5i m\u1edbi y h\u1ecdc n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Chi\u1ebfn L\u01b0\u1ee3c Giao D\u1ecbch<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>1,62 USD<\/strong>, t\u1ea1o ra m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 quan t\u00e2m \u0111\u1ebfn l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. C\u1ed5 phi\u1ebfu \u0111\u00e3 tr\u1ea3i qua s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 g\u1ea7n \u0111\u00e2y, khi\u1ebfn vi\u1ec7c ch\u1ecdn th\u1eddi \u0111i\u1ec3m tr\u1edf n\u00ean quan tr\u1ecdng \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1i \u01b0u.<\/p> <p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng<\/strong>: H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n v\u00e0o <strong>ng\u00e0y 13 th\u00e1ng 11 n\u0103m 2025<\/strong> \u2014 \u0111\u00e2y l\u00e0 th\u1eddi \u0111i\u1ec3m Cardiol Therapeutics c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo. C\u00e1c m\u1eabu h\u00ecnh l\u1ecbch s\u1eed cho th\u1ea5y nh\u1eefng th\u00f4ng b\u00e1o n\u00e0y c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t c\u00e1c bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <p>Nh\u00ecn l\u1ea1i t\u00e1c \u0111\u1ed9ng c\u1ee7a b\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n \u0111\u00e2y, b\u00e1o c\u00e1o ng\u00e0y 14 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 cho th\u1ea5y c\u00e1ch c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng ph\u1ea3n \u1ee9ng v\u1edbi tin t\u1ee9c. C\u00f4ng ty b\u00e1o c\u00e1o EPS l\u00e0 -0,07 USD, v\u01b0\u1ee3t xa \u01b0\u1edbc t\u00ednh \u0111\u1ed3ng thu\u1eadn l\u00e0 -0,11 USD t\u1edbi 36% (<a href=\"https:\/\/public.com\/stocks\/crdl\/earnings\">B\u00e1o c\u00e1o Thu nh\u1eadp Q2 2025<\/a>). B\u1ea5t ng\u1edd t\u00edch c\u1ef1c n\u00e0y th\u01b0\u1eddng t\u1ea1o \u0111\u1ed9ng l\u1ef1c t\u0103ng gi\u00e1, m\u1eb7c d\u00f9 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng cao c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f3 ngh\u0129a l\u00e0 ph\u1ea3n \u1ee9ng c\u00f3 th\u1ec3 kh\u00f3 \u0111o\u00e1n.<\/p> <h3>Ph\u00e2n T\u00edch Hi\u1ec7u Su\u1ea5t Gi\u00e1 G\u1ea7n \u0110\u00e2y<\/h3> <p>Trong s\u00e1u th\u00e1ng qua, CRDL \u0111\u00e3 th\u1ec3 hi\u1ec7n m\u00f4 h\u00ecnh bi\u1ebfn \u0111\u1ed9ng nh\u01b0 t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c \u0111\u1eb7c tr\u01b0ng c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng:<\/p> <ul> <li><strong>Th\u00e1ng 2-3 n\u0103m 2025<\/strong>: C\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng 1,70-1,90 USD khi c\u00f4ng ty ti\u1ebfn tri\u1ec3n c\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II<\/li> <li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng kho\u1ea3ng 1,45 USD sau khi ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u00ean th\u1ecb tr\u01b0\u1eddng r\u1ed9ng l\u1edbn y\u1ebfu \u0111i<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean 1,85 USD nh\u1edd k\u1ef3 v\u1ecdng t\u00edch c\u1ef1c v\u1ec1 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li> <li><strong>Th\u00e1ng 6-7 n\u0103m 2025<\/strong>: T\u00edch l\u0169y trong kho\u1ea3ng 1,60-1,75 USD ch\u1edd k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: Hi\u1ec7n t\u1ea1i \u1edf m\u1ee9c 1,62 USD sau b\u00e1o c\u00e1o thu nh\u1eadp, th\u1ec3 hi\u1ec7n s\u1ef1 b\u1ec1n b\u1ec9 b\u1ea5t ch\u1ea5p bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/li> <\/ul> <p>Beta c\u1ee7a c\u1ed5 phi\u1ebfu l\u00e0 1,70 cho th\u1ea5y n\u00f3 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh h\u01a1n \u0111\u00e1ng k\u1ec3 so v\u1edbi th\u1ecb tr\u01b0\u1eddng chung, di chuy\u1ec3n kho\u1ea3ng 70% nhi\u1ec1u h\u01a1n c\u00e1c ch\u1ec9 s\u1ed1 ch\u00ednh (<a href=\"https:\/\/marketchameleon.com\/Overview\/CRDL\/Summary\/\">D\u1eef li\u1ec7u Bi\u1ebfn \u0111\u1ed9ng Th\u1ecb tr\u01b0\u1eddng<\/a>). S\u1ef1 bi\u1ebfn \u0111\u1ed9ng n\u00e0y t\u1ea1o ra c\u1ea3 r\u1ee7i ro v\u00e0 c\u01a1 h\u1ed9i cho c\u00e1c nh\u00e0 giao d\u1ecbch.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean c\u00e1c d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c m\u1ed1c ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i cho CRDL:<\/p> <p><strong>M\u1ee5c Ti\u00eau Cu\u1ed1i N\u0103m 2025<\/strong>: 2,50-3,00 USD (ti\u1ec1m n\u0103ng t\u0103ng 54-85%)<\/p> <ul> <li>\u0110\u01b0\u1ee3c th\u00fac \u0111\u1ea9y b\u1edfi ti\u1ebfn tri\u1ec3n li\u00ean t\u1ee5c c\u1ee7a th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II v\u00e0 c\u00e1c th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c ti\u1ec1m n\u0103ng<\/li> <\/ul> <p><strong>D\u1ef1 B\u00e1o 2026<\/strong>: 4,00-5,00 USD <\/p> <ul> <li>Gi\u1ea3 \u0111\u1ecbnh ho\u00e0n th\u00e0nh th\u00e0nh c\u00f4ng Giai \u0111o\u1ea1n II v\u00e0 kh\u1edfi \u0111\u1ed9ng Giai \u0111o\u1ea1n III<\/li> <\/ul> <p><strong>D\u1ef1 B\u00e1o 2028<\/strong>: 6,00-8,00 USD<\/p> <ul> <li>Kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t FDA cho \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u CardiolRx\u2122<\/li> <\/ul> <p><strong>T\u1ea7m Nh\u00ecn D\u00e0i H\u1ea1n 2030<\/strong>: Tr\u00ean 10,00 USD<\/p> <ul> <li>Th\u00e0nh c\u00f4ng trong th\u01b0\u01a1ng m\u1ea1i h\u00f3a v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c s\u1ea3n ph\u1ea9m<\/li> <\/ul> <p><strong>K\u1ebft Lu\u1eadn<\/strong>: MUA M\u1ea0NH cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 3-5 n\u0103m. Gi\u00e1 hi\u1ec7n t\u1ea1i \u0111\u1ea1i di\u1ec7n cho \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn tr\u01b0\u1edbc c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng l\u1edbn.<\/p> <h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro so v\u1edbi C\u00e1c T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>C\u00e1c R\u1ee7i Ro Ti\u1ec1m \u1ea8n C\u1ea7n Xem X\u00e9t:<\/h3> <ul> <li><strong>R\u1ee7i Ro Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: C\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II\/III c\u00f3 th\u1ec3 cho k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c<\/li> <li><strong>Lo Ng\u1ea1i V\u1ec1 Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: C\u00f4ng ty b\u00e1o c\u00e1o l\u1ed7 r\u00f2ng 8,35 tri\u1ec7u USD trong Q2 2025 v\u1edbi ti\u1ec1n m\u1eb7t gi\u1ea3m t\u1eeb 30,6 tri\u1ec7u USD xu\u1ed1ng c\u00f2n 18,2 tri\u1ec7u USD (<a href=\"https:\/\/www.ainvest.com\/news\/cardiol-therapeutics-reports-q2-2025-financial-results-rising-losses-ongoing-investments-research-development-2508\/\">Ph\u00e2n T\u00edch T\u00e0i Ch\u00ednh<\/a>)<\/li> <li><strong>R\u00e0o C\u1ea3n Ph\u00e1p L\u00fd<\/strong>: S\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn trong quy tr\u00ecnh ph\u00ea duy\u1ec7t FDA<\/li> <li><strong>Bi\u1ebfn \u0110\u1ed9ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Beta cao 1,70 ngh\u0129a l\u00e0 dao \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng \u0111\u01b0\u1ee3c khu\u1ebfch \u0111\u1ea1i<\/li> <li><strong>R\u1ee7i Ro Pha Lo\u00e3ng<\/strong>: Kh\u1ea3 n\u0103ng ph\u00e1t h\u00e0nh c\u1ed5 phi\u1ebfu trong t\u01b0\u01a1ng lai \u0111\u1ec3 t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng<\/li> <\/ul> <h3>C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c T\u00edch C\u1ef1c cho 2025:<\/h3> <ul> <li><strong>Th\u00e0nh C\u00f4ng Giai \u0110o\u1ea1n II<\/strong>: Th\u1eed nghi\u1ec7m ARCHER cho th\u1ea5y c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 th\u1ec3 t\u00edch ngo\u1ea1i b\u00e0o (p = 0,0538) cho vi\u00eam c\u01a1 tim c\u1ea5p (<a href=\"https:\/\/www.cardiolrx.com\/cardiol-therapeutics-announces-topline-results-from-the-phase-ii-archer-trial-of-cardiolrx-in-acute-myocarditis\/\">K\u1ebft Qu\u1ea3 Th\u1eed Nghi\u1ec7m<\/a>)<\/li> <li><strong>Ch\u1ec9 \u0110\u1ecbnh Thu\u1ed1c M\u1ed3 C\u00f4i<\/strong>: CardiolRx\u2122 nh\u1eadn \u0111\u01b0\u1ee3c tr\u1ea1ng th\u00e1i n\u00e0y cho vi\u00eam m\u00e0ng ngo\u00e0i tim, cung c\u1ea5p \u0111\u1ed9c quy\u1ec1n th\u1ecb tr\u01b0\u1eddng<\/li> <li><strong>L\u1ea1c Quan T\u1eeb C\u00e1c Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: M\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 8,00-9,00 USD t\u01b0\u01a1ng \u1ee9ng ti\u1ec1m n\u0103ng t\u0103ng 400-455% (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/CRDL\/forecast\/\">M\u1ee5c Ti\u00eau Nh\u00e0 Ph\u00e2n T\u00edch<\/a>)<\/li> <li><strong>Xu H\u01b0\u1edbng Ng\u00e0nh<\/strong>: T\u0103ng c\u01b0\u1eddng t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb vi\u00eam tim m\u1ea1ch<\/li> <li><strong>Ban L\u00e3nh \u0110\u1ea1o M\u1ea1nh M\u1ebd<\/strong>: C\u00e1c cu\u1ed9c b\u1ecf phi\u1ebfu c\u1ed5 \u0111\u00f4ng g\u1ea7n \u0111\u00e2y cho th\u1ea5y h\u01a1n 92% \u0111\u1ed3ng thu\u1eadn cho t\u1ea5t c\u1ea3 c\u00e1c \u1ee9ng vi\u00ean h\u1ed9i \u0111\u1ed3ng qu\u1ea3n tr\u1ecb<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi H\u00f4m Nay<\/h2> <p><strong>B\u1ea1n n\u00ean l\u00e0m g\u00ec ngay b\u00e2y gi\u1edd?<\/strong> \u0110\u00e2y l\u00e0 l\u1eddi khuy\u00ean chuy\u00ean nghi\u1ec7p c\u1ee7a t\u00f4i:<\/p> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-3% danh m\u1ee5c \u0111\u1ea7u t\u01b0 cho CRDL \u2014 \u0111\u00e2y l\u00e0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 Mua<\/strong>: Mua theo t\u1eebng ph\u1ea7n trong v\u00e0i tu\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o<\/li> <li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 v\u1ed1n v\u1edbi l\u1ec7nh c\u1eaft l\u1ed7 15-20%<\/li> <li><strong>Gi\u00e1m S\u00e1t C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11 v\u00e0 c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li> <\/ol> <p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a nh\u00e0 giao d\u1ecbch k\u1ef3 c\u1ef1u<\/strong>: \"Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 CRDL gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 nh\u1eefng \u0111\u1ed9t ph\u00e1 th\u00fa v\u1ecb xen k\u1ebd v\u1edbi nh\u1eefng kho\u1ea3ng l\u1eb7ng v\u00e0 ph\u1ea3n \u1ee9ng b\u00f9ng n\u1ed5 th\u1ec9nh tho\u1ea3ng. Lu\u00f4n gi\u1eef chi\u1ebfn l\u01b0\u1ee3c tho\u00e1t hi\u1ec3m kh\u1ea9n c\u1ea5p!\"<\/p> <h2>\u2705 H\u01b0\u1edbng D\u1eabn T\u1eebng B\u01b0\u1edbc: C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng cung c\u1ea5p danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh T\u00e0i Kho\u1ea3n<\/td><td>Cung c\u1ea5p c\u00e1c gi\u1ea5y t\u1edd c\u1ea7n thi\u1ebft \u0111\u1ec3 tu\u00e2n th\u1ee7 quy \u0111\u1ecbnh<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n c\u00f3 th\u1ec3 qu\u1ea3n l\u00fd v\u00e0 b\u1ea1n c\u00f3 th\u1ec3 ch\u1ea5p nh\u1eadn r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>Nghi\u00ean C\u1ee9u K\u1ef9 L\u01b0\u1ee1ng CRDL<\/td><td>Hi\u1ec3u r\u00f5 danh m\u1ee5c s\u1ea3n ph\u1ea9m v\u00e0 c\u00e1c r\u1ee7i ro c\u1ee7a c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>\u0110\u1eb7t L\u1ec7nh Gi\u1edbi H\u1ea1n<\/td><td>\u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/td><\/tr> <tr><td>6<\/td><td>Gi\u00e1m S\u00e1t V\u1ecb Th\u1ebf C\u1ee7a B\u1ea1n<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 cho c\u00e1c m\u1ee9c quan tr\u1ecdng<\/td><\/tr> <tr><td>7<\/td><td>\u0110\u00e1nh Gi\u00e1 \u0110\u1ecbnh K\u1ef3<\/td><td>\u0110\u00e1nh gi\u00e1 l\u1ea1i lu\u1eadn \u0111i\u1ec3m \u0111\u1ea7u t\u01b0 h\u00e0ng qu\u00fd<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt Cho Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p c\u00e1c l\u1ee3i th\u1ebf v\u01b0\u1ee3t tr\u1ed9i khi giao d\u1ecbch c\u00e1c c\u1ed5 phi\u1ebfu nh\u01b0 CRDL:<\/p> <ul> <li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u<\/strong>: Ch\u1ec9 5 USD \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u<\/li> <li><strong>X\u00e1c Minh Nhanh<\/strong>: Quy tr\u00ecnh KYC 1 ph\u00fat s\u1eed d\u1ee5ng b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n ch\u00ednh ph\u1ee7 n\u00e0o<\/li> <li><strong>T\u00f9y Ch\u1ecdn R\u00fat Ti\u1ec1n<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 th\u1ebb ng\u00e2n h\u00e0ng<\/li> <li><strong>N\u1ec1n T\u1ea3ng Th\u00e2n Thi\u1ec7n Ng\u01b0\u1eddi D\u00f9ng<\/strong>: Giao di\u1ec7n tr\u1ef1c quan thi\u1ebft k\u1ebf cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u<\/li> <li><strong>T\u00e0i Nguy\u00ean Gi\u00e1o D\u1ee5c<\/strong>: T\u00e0i li\u1ec7u h\u1ecdc t\u1eadp to\u00e0n di\u1ec7n tr\u00ean blog c\u1ee7a Pocket Option<\/li> <\/ul> <p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p n\u00e0y r\u1ea5t l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n b\u1eaft \u0111\u1ea7u nh\u1ecf trong khi h\u1ecdc c\u00e1c chi ti\u1ebft ph\u1ee9c t\u1ea1p c\u1ee7a giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h2>\ud83c\udf0d Cardiol Therapeutics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi<\/h2> <p>Cardiol Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi y h\u1ecdc tim m\u1ea1ch. C\u00f4ng ty chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p ch\u1ed1ng vi\u00eam v\u00e0 ch\u1ed1ng x\u01a1 h\u00f3a cho c\u00e1c b\u1ec7nh tim \u2014 nh\u1eefng c\u0103n b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u v\u1edbi c\u00e1c l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb h\u1ea1n ch\u1ebf.<\/p> <p><strong>C\u00e1c L\u0129nh V\u1ef1c T\u1eadp Trung Hi\u1ec7n T\u1ea1i<\/strong>:<\/p> <ul> <li>CardiolRx\u2122 cho vi\u00eam c\u01a1 tim c\u1ea5p v\u00e0 vi\u00eam m\u00e0ng ngo\u00e0i tim t\u00e1i ph\u00e1t<\/li> <li>C\u00f4ng th\u1ee9c ti\u00eam d\u01b0\u1edbi da CRD-38 cho suy tim<\/li> <li>\u0110i\u1ec1u tr\u1ecb \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i cho c\u00e1c b\u1ec7nh tim hi\u1ebfm g\u1eb7p<\/li> <\/ul> <p>K\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II ARCHER g\u1ea7n \u0111\u00e2y c\u1ee7a c\u00f4ng ty cho th\u1ea5y ho\u1ea1t \u0111\u1ed9ng \u0111\u1ea7y h\u1ee9a h\u1eb9n trong vi\u00eam c\u01a1 tim c\u1ea5p, m\u1ed9t t\u00ecnh tr\u1ea1ng ch\u01b0a c\u00f3 li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t (<a href=\"https:\/\/thedeepdive.ca\/cardiol-therapeutics-releases-positive-topline-results-from-phase-ii-clinical-trial\/\">Ti\u1ebfn Tr\u00ecnh L\u00e2m S\u00e0ng<\/a>). \u0110i\u1ec1u n\u00e0y \u0111\u1eb7t Cardiol v\u00e0o v\u1ecb tr\u00ed ti\u1ec1m n\u0103ng tr\u1edf th\u00e0nh nh\u00e0 l\u00e3nh \u0111\u1ea1o trong m\u1ed9t th\u1ecb tr\u01b0\u1eddng ch\u01b0a \u0111\u01b0\u1ee3c ph\u1ee5c v\u1ee5 \u0111\u1ea7y \u0111\u1ee7.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, Cardiol Therapeutics tr\u1edf th\u00e0nh m\u1ed9t trong s\u1ed1 \u00edt c\u00e1c c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ho\u00e0n th\u00e0nh th\u00e0nh c\u00f4ng th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II \u0111a qu\u1ed1c gia trong b\u1ed1i c\u1ea3nh th\u00e1ch th\u1ee9c chu\u1ed7i cung \u1ee9ng to\u00e0n c\u1ea7u, tuy\u1ec3n d\u1ee5ng b\u1ec7nh nh\u00e2n t\u1eeb M\u1ef9, Ph\u00e1p, Brazil v\u00e0 Israel m\u00e0 kh\u00f4ng c\u00f3 s\u1ef1 ch\u1eadm tr\u1ec5 \u0111\u00e1ng k\u1ec3 \u2014 minh ch\u1ee9ng cho s\u1ef1 xu\u1ea5t s\u1eafc trong v\u1eadn h\u00e0nh nghi\u00ean c\u1ee9u l\u00e2m s\u00e0ng c\u1ee7a h\u1ecd.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Chi\u1ebfn L\u01b0\u1ee3c Giao D\u1ecbch<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>1,62 USD<\/strong>, t\u1ea1o ra m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 quan t\u00e2m \u0111\u1ebfn l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. C\u1ed5 phi\u1ebfu \u0111\u00e3 tr\u1ea3i qua s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 g\u1ea7n \u0111\u00e2y, khi\u1ebfn vi\u1ec7c ch\u1ecdn th\u1eddi \u0111i\u1ec3m tr\u1edf n\u00ean quan tr\u1ecdng \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1i \u01b0u.<\/p>\n<p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng<\/strong>: H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n v\u00e0o <strong>ng\u00e0y 13 th\u00e1ng 11 n\u0103m 2025<\/strong> \u2014 \u0111\u00e2y l\u00e0 th\u1eddi \u0111i\u1ec3m Cardiol Therapeutics c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo. C\u00e1c m\u1eabu h\u00ecnh l\u1ecbch s\u1eed cho th\u1ea5y nh\u1eefng th\u00f4ng b\u00e1o n\u00e0y c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t c\u00e1c bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<p>Nh\u00ecn l\u1ea1i t\u00e1c \u0111\u1ed9ng c\u1ee7a b\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n \u0111\u00e2y, b\u00e1o c\u00e1o ng\u00e0y 14 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 cho th\u1ea5y c\u00e1ch c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng ph\u1ea3n \u1ee9ng v\u1edbi tin t\u1ee9c. C\u00f4ng ty b\u00e1o c\u00e1o EPS l\u00e0 -0,07 USD, v\u01b0\u1ee3t xa \u01b0\u1edbc t\u00ednh \u0111\u1ed3ng thu\u1eadn l\u00e0 -0,11 USD t\u1edbi 36% (<a href=\"https:\/\/public.com\/stocks\/crdl\/earnings\">B\u00e1o c\u00e1o Thu nh\u1eadp Q2 2025<\/a>). B\u1ea5t ng\u1edd t\u00edch c\u1ef1c n\u00e0y th\u01b0\u1eddng t\u1ea1o \u0111\u1ed9ng l\u1ef1c t\u0103ng gi\u00e1, m\u1eb7c d\u00f9 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng cao c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f3 ngh\u0129a l\u00e0 ph\u1ea3n \u1ee9ng c\u00f3 th\u1ec3 kh\u00f3 \u0111o\u00e1n.<\/p>\n<h3>Ph\u00e2n T\u00edch Hi\u1ec7u Su\u1ea5t Gi\u00e1 G\u1ea7n \u0110\u00e2y<\/h3>\n<p>Trong s\u00e1u th\u00e1ng qua, CRDL \u0111\u00e3 th\u1ec3 hi\u1ec7n m\u00f4 h\u00ecnh bi\u1ebfn \u0111\u1ed9ng nh\u01b0 t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c \u0111\u1eb7c tr\u01b0ng c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2-3 n\u0103m 2025<\/strong>: C\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng 1,70-1,90 USD khi c\u00f4ng ty ti\u1ebfn tri\u1ec3n c\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II<\/li>\n<li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng kho\u1ea3ng 1,45 USD sau khi ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u00ean th\u1ecb tr\u01b0\u1eddng r\u1ed9ng l\u1edbn y\u1ebfu \u0111i<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean 1,85 USD nh\u1edd k\u1ef3 v\u1ecdng t\u00edch c\u1ef1c v\u1ec1 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li>\n<li><strong>Th\u00e1ng 6-7 n\u0103m 2025<\/strong>: T\u00edch l\u0169y trong kho\u1ea3ng 1,60-1,75 USD ch\u1edd k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: Hi\u1ec7n t\u1ea1i \u1edf m\u1ee9c 1,62 USD sau b\u00e1o c\u00e1o thu nh\u1eadp, th\u1ec3 hi\u1ec7n s\u1ef1 b\u1ec1n b\u1ec9 b\u1ea5t ch\u1ea5p bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/li>\n<\/ul>\n<p>Beta c\u1ee7a c\u1ed5 phi\u1ebfu l\u00e0 1,70 cho th\u1ea5y n\u00f3 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh h\u01a1n \u0111\u00e1ng k\u1ec3 so v\u1edbi th\u1ecb tr\u01b0\u1eddng chung, di chuy\u1ec3n kho\u1ea3ng 70% nhi\u1ec1u h\u01a1n c\u00e1c ch\u1ec9 s\u1ed1 ch\u00ednh (<a href=\"https:\/\/marketchameleon.com\/Overview\/CRDL\/Summary\/\">D\u1eef li\u1ec7u Bi\u1ebfn \u0111\u1ed9ng Th\u1ecb tr\u01b0\u1eddng<\/a>). S\u1ef1 bi\u1ebfn \u0111\u1ed9ng n\u00e0y t\u1ea1o ra c\u1ea3 r\u1ee7i ro v\u00e0 c\u01a1 h\u1ed9i cho c\u00e1c nh\u00e0 giao d\u1ecbch.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean c\u00e1c d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c m\u1ed1c ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i cho CRDL:<\/p>\n<p><strong>M\u1ee5c Ti\u00eau Cu\u1ed1i N\u0103m 2025<\/strong>: 2,50-3,00 USD (ti\u1ec1m n\u0103ng t\u0103ng 54-85%)<\/p>\n<ul>\n<li>\u0110\u01b0\u1ee3c th\u00fac \u0111\u1ea9y b\u1edfi ti\u1ebfn tri\u1ec3n li\u00ean t\u1ee5c c\u1ee7a th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II v\u00e0 c\u00e1c th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c ti\u1ec1m n\u0103ng<\/li>\n<\/ul>\n<p><strong>D\u1ef1 B\u00e1o 2026<\/strong>: 4,00-5,00 USD <\/p>\n<ul>\n<li>Gi\u1ea3 \u0111\u1ecbnh ho\u00e0n th\u00e0nh th\u00e0nh c\u00f4ng Giai \u0111o\u1ea1n II v\u00e0 kh\u1edfi \u0111\u1ed9ng Giai \u0111o\u1ea1n III<\/li>\n<\/ul>\n<p><strong>D\u1ef1 B\u00e1o 2028<\/strong>: 6,00-8,00 USD<\/p>\n<ul>\n<li>Kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t FDA cho \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u CardiolRx\u2122<\/li>\n<\/ul>\n<p><strong>T\u1ea7m Nh\u00ecn D\u00e0i H\u1ea1n 2030<\/strong>: Tr\u00ean 10,00 USD<\/p>\n<ul>\n<li>Th\u00e0nh c\u00f4ng trong th\u01b0\u01a1ng m\u1ea1i h\u00f3a v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c s\u1ea3n ph\u1ea9m<\/li>\n<\/ul>\n<p><strong>K\u1ebft Lu\u1eadn<\/strong>: MUA M\u1ea0NH cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 3-5 n\u0103m. Gi\u00e1 hi\u1ec7n t\u1ea1i \u0111\u1ea1i di\u1ec7n cho \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn tr\u01b0\u1edbc c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng l\u1edbn.<\/p>\n<h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro so v\u1edbi C\u00e1c T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>C\u00e1c R\u1ee7i Ro Ti\u1ec1m \u1ea8n C\u1ea7n Xem X\u00e9t:<\/h3>\n<ul>\n<li><strong>R\u1ee7i Ro Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: C\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II\/III c\u00f3 th\u1ec3 cho k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c<\/li>\n<li><strong>Lo Ng\u1ea1i V\u1ec1 Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: C\u00f4ng ty b\u00e1o c\u00e1o l\u1ed7 r\u00f2ng 8,35 tri\u1ec7u USD trong Q2 2025 v\u1edbi ti\u1ec1n m\u1eb7t gi\u1ea3m t\u1eeb 30,6 tri\u1ec7u USD xu\u1ed1ng c\u00f2n 18,2 tri\u1ec7u USD (<a href=\"https:\/\/www.ainvest.com\/news\/cardiol-therapeutics-reports-q2-2025-financial-results-rising-losses-ongoing-investments-research-development-2508\/\">Ph\u00e2n T\u00edch T\u00e0i Ch\u00ednh<\/a>)<\/li>\n<li><strong>R\u00e0o C\u1ea3n Ph\u00e1p L\u00fd<\/strong>: S\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn trong quy tr\u00ecnh ph\u00ea duy\u1ec7t FDA<\/li>\n<li><strong>Bi\u1ebfn \u0110\u1ed9ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Beta cao 1,70 ngh\u0129a l\u00e0 dao \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng \u0111\u01b0\u1ee3c khu\u1ebfch \u0111\u1ea1i<\/li>\n<li><strong>R\u1ee7i Ro Pha Lo\u00e3ng<\/strong>: Kh\u1ea3 n\u0103ng ph\u00e1t h\u00e0nh c\u1ed5 phi\u1ebfu trong t\u01b0\u01a1ng lai \u0111\u1ec3 t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng<\/li>\n<\/ul>\n<h3>C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c T\u00edch C\u1ef1c cho 2025:<\/h3>\n<ul>\n<li><strong>Th\u00e0nh C\u00f4ng Giai \u0110o\u1ea1n II<\/strong>: Th\u1eed nghi\u1ec7m ARCHER cho th\u1ea5y c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 th\u1ec3 t\u00edch ngo\u1ea1i b\u00e0o (p = 0,0538) cho vi\u00eam c\u01a1 tim c\u1ea5p (<a href=\"https:\/\/www.cardiolrx.com\/cardiol-therapeutics-announces-topline-results-from-the-phase-ii-archer-trial-of-cardiolrx-in-acute-myocarditis\/\">K\u1ebft Qu\u1ea3 Th\u1eed Nghi\u1ec7m<\/a>)<\/li>\n<li><strong>Ch\u1ec9 \u0110\u1ecbnh Thu\u1ed1c M\u1ed3 C\u00f4i<\/strong>: CardiolRx\u2122 nh\u1eadn \u0111\u01b0\u1ee3c tr\u1ea1ng th\u00e1i n\u00e0y cho vi\u00eam m\u00e0ng ngo\u00e0i tim, cung c\u1ea5p \u0111\u1ed9c quy\u1ec1n th\u1ecb tr\u01b0\u1eddng<\/li>\n<li><strong>L\u1ea1c Quan T\u1eeb C\u00e1c Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: M\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 8,00-9,00 USD t\u01b0\u01a1ng \u1ee9ng ti\u1ec1m n\u0103ng t\u0103ng 400-455% (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/CRDL\/forecast\/\">M\u1ee5c Ti\u00eau Nh\u00e0 Ph\u00e2n T\u00edch<\/a>)<\/li>\n<li><strong>Xu H\u01b0\u1edbng Ng\u00e0nh<\/strong>: T\u0103ng c\u01b0\u1eddng t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb vi\u00eam tim m\u1ea1ch<\/li>\n<li><strong>Ban L\u00e3nh \u0110\u1ea1o M\u1ea1nh M\u1ebd<\/strong>: C\u00e1c cu\u1ed9c b\u1ecf phi\u1ebfu c\u1ed5 \u0111\u00f4ng g\u1ea7n \u0111\u00e2y cho th\u1ea5y h\u01a1n 92% \u0111\u1ed3ng thu\u1eadn cho t\u1ea5t c\u1ea3 c\u00e1c \u1ee9ng vi\u00ean h\u1ed9i \u0111\u1ed3ng qu\u1ea3n tr\u1ecb<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi H\u00f4m Nay<\/h2>\n<p><strong>B\u1ea1n n\u00ean l\u00e0m g\u00ec ngay b\u00e2y gi\u1edd?<\/strong> \u0110\u00e2y l\u00e0 l\u1eddi khuy\u00ean chuy\u00ean nghi\u1ec7p c\u1ee7a t\u00f4i:<\/p>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-3% danh m\u1ee5c \u0111\u1ea7u t\u01b0 cho CRDL \u2014 \u0111\u00e2y l\u00e0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 Mua<\/strong>: Mua theo t\u1eebng ph\u1ea7n trong v\u00e0i tu\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o<\/li>\n<li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 v\u1ed1n v\u1edbi l\u1ec7nh c\u1eaft l\u1ed7 15-20%<\/li>\n<li><strong>Gi\u00e1m S\u00e1t C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11 v\u00e0 c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li>\n<\/ol>\n<p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a nh\u00e0 giao d\u1ecbch k\u1ef3 c\u1ef1u<\/strong>: &#8220;Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 CRDL gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 nh\u1eefng \u0111\u1ed9t ph\u00e1 th\u00fa v\u1ecb xen k\u1ebd v\u1edbi nh\u1eefng kho\u1ea3ng l\u1eb7ng v\u00e0 ph\u1ea3n \u1ee9ng b\u00f9ng n\u1ed5 th\u1ec9nh tho\u1ea3ng. Lu\u00f4n gi\u1eef chi\u1ebfn l\u01b0\u1ee3c tho\u00e1t hi\u1ec3m kh\u1ea9n c\u1ea5p!&#8221;<\/p>\n<h2>\u2705 H\u01b0\u1edbng D\u1eabn T\u1eebng B\u01b0\u1edbc: C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng cung c\u1ea5p danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh T\u00e0i Kho\u1ea3n<\/td>\n<td>Cung c\u1ea5p c\u00e1c gi\u1ea5y t\u1edd c\u1ea7n thi\u1ebft \u0111\u1ec3 tu\u00e2n th\u1ee7 quy \u0111\u1ecbnh<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n c\u00f3 th\u1ec3 qu\u1ea3n l\u00fd v\u00e0 b\u1ea1n c\u00f3 th\u1ec3 ch\u1ea5p nh\u1eadn r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Nghi\u00ean C\u1ee9u K\u1ef9 L\u01b0\u1ee1ng CRDL<\/td>\n<td>Hi\u1ec3u r\u00f5 danh m\u1ee5c s\u1ea3n ph\u1ea9m v\u00e0 c\u00e1c r\u1ee7i ro c\u1ee7a c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0110\u1eb7t L\u1ec7nh Gi\u1edbi H\u1ea1n<\/td>\n<td>\u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Gi\u00e1m S\u00e1t V\u1ecb Th\u1ebf C\u1ee7a B\u1ea1n<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 cho c\u00e1c m\u1ee9c quan tr\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u0110\u00e1nh Gi\u00e1 \u0110\u1ecbnh K\u1ef3<\/td>\n<td>\u0110\u00e1nh gi\u00e1 l\u1ea1i lu\u1eadn \u0111i\u1ec3m \u0111\u1ea7u t\u01b0 h\u00e0ng qu\u00fd<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt Cho Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p c\u00e1c l\u1ee3i th\u1ebf v\u01b0\u1ee3t tr\u1ed9i khi giao d\u1ecbch c\u00e1c c\u1ed5 phi\u1ebfu nh\u01b0 CRDL:<\/p>\n<ul>\n<li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u<\/strong>: Ch\u1ec9 5 USD \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u<\/li>\n<li><strong>X\u00e1c Minh Nhanh<\/strong>: Quy tr\u00ecnh KYC 1 ph\u00fat s\u1eed d\u1ee5ng b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n ch\u00ednh ph\u1ee7 n\u00e0o<\/li>\n<li><strong>T\u00f9y Ch\u1ecdn R\u00fat Ti\u1ec1n<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 th\u1ebb ng\u00e2n h\u00e0ng<\/li>\n<li><strong>N\u1ec1n T\u1ea3ng Th\u00e2n Thi\u1ec7n Ng\u01b0\u1eddi D\u00f9ng<\/strong>: Giao di\u1ec7n tr\u1ef1c quan thi\u1ebft k\u1ebf cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u<\/li>\n<li><strong>T\u00e0i Nguy\u00ean Gi\u00e1o D\u1ee5c<\/strong>: T\u00e0i li\u1ec7u h\u1ecdc t\u1eadp to\u00e0n di\u1ec7n tr\u00ean blog c\u1ee7a Pocket Option<\/li>\n<\/ul>\n<p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p n\u00e0y r\u1ea5t l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n b\u1eaft \u0111\u1ea7u nh\u1ecf trong khi h\u1ecdc c\u00e1c chi ti\u1ebft ph\u1ee9c t\u1ea1p c\u1ee7a giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h2>\ud83c\udf0d Cardiol Therapeutics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi<\/h2>\n<p>Cardiol Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi y h\u1ecdc tim m\u1ea1ch. C\u00f4ng ty chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p ch\u1ed1ng vi\u00eam v\u00e0 ch\u1ed1ng x\u01a1 h\u00f3a cho c\u00e1c b\u1ec7nh tim \u2014 nh\u1eefng c\u0103n b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u v\u1edbi c\u00e1c l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb h\u1ea1n ch\u1ebf.<\/p>\n<p><strong>C\u00e1c L\u0129nh V\u1ef1c T\u1eadp Trung Hi\u1ec7n T\u1ea1i<\/strong>:<\/p>\n<ul>\n<li>CardiolRx\u2122 cho vi\u00eam c\u01a1 tim c\u1ea5p v\u00e0 vi\u00eam m\u00e0ng ngo\u00e0i tim t\u00e1i ph\u00e1t<\/li>\n<li>C\u00f4ng th\u1ee9c ti\u00eam d\u01b0\u1edbi da CRD-38 cho suy tim<\/li>\n<li>\u0110i\u1ec1u tr\u1ecb \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i cho c\u00e1c b\u1ec7nh tim hi\u1ebfm g\u1eb7p<\/li>\n<\/ul>\n<p>K\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II ARCHER g\u1ea7n \u0111\u00e2y c\u1ee7a c\u00f4ng ty cho th\u1ea5y ho\u1ea1t \u0111\u1ed9ng \u0111\u1ea7y h\u1ee9a h\u1eb9n trong vi\u00eam c\u01a1 tim c\u1ea5p, m\u1ed9t t\u00ecnh tr\u1ea1ng ch\u01b0a c\u00f3 li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t (<a href=\"https:\/\/thedeepdive.ca\/cardiol-therapeutics-releases-positive-topline-results-from-phase-ii-clinical-trial\/\">Ti\u1ebfn Tr\u00ecnh L\u00e2m S\u00e0ng<\/a>). \u0110i\u1ec1u n\u00e0y \u0111\u1eb7t Cardiol v\u00e0o v\u1ecb tr\u00ed ti\u1ec1m n\u0103ng tr\u1edf th\u00e0nh nh\u00e0 l\u00e3nh \u0111\u1ea1o trong m\u1ed9t th\u1ecb tr\u01b0\u1eddng ch\u01b0a \u0111\u01b0\u1ee3c ph\u1ee5c v\u1ee5 \u0111\u1ea7y \u0111\u1ee7.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, Cardiol Therapeutics tr\u1edf th\u00e0nh m\u1ed9t trong s\u1ed1 \u00edt c\u00e1c c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ho\u00e0n th\u00e0nh th\u00e0nh c\u00f4ng th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II \u0111a qu\u1ed1c gia trong b\u1ed1i c\u1ea3nh th\u00e1ch th\u1ee9c chu\u1ed7i cung \u1ee9ng to\u00e0n c\u1ea7u, tuy\u1ec3n d\u1ee5ng b\u1ec7nh nh\u00e2n t\u1eeb M\u1ef9, Ph\u00e1p, Brazil v\u00e0 Israel m\u00e0 kh\u00f4ng c\u00f3 s\u1ef1 ch\u1eadm tr\u1ec5 \u0111\u00e1ng k\u1ec3 \u2014 minh ch\u1ee9ng cho s\u1ef1 xu\u1ea5t s\u1eafc trong v\u1eadn h\u00e0nh nghi\u00ean c\u1ee9u l\u00e2m s\u00e0ng c\u1ee7a h\u1ecd.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CRDL th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch cung c\u1ea5p c\u1ed5 phi\u1ebfu NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng uy t\u00edn, ho\u00e0n th\u00e0nh x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n ph\u00f9 h\u1ee3p."},{"question":"Cardiol Therapeutics Inc. (CRDL) c\u00f3 ph\u1ea3i l\u00e0 m\u1ed9t kho\u1ea3n \u0111\u1ea7u t\u01b0 r\u1ee7i ro cao kh\u00f4ng?","answer":"C\u00f3, CRDL l\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng v\u1edbi bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 r\u1ee7i ro li\u00ean quan \u0111\u1ebfn k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 quy tr\u00ecnh ph\u00ea duy\u1ec7t FDA. Nh\u00e0 \u0111\u1ea7u t\u01b0 n\u00ean c\u00e2n nh\u1eafc k\u1ef9 v\u00e0 ch\u1ec9 \u0111\u1ea7u t\u01b0 m\u1ed9t ph\u1ea7n nh\u1ecf danh m\u1ee5c."},{"question":"C\u00e1c ch\u1ea5t x\u00fac t\u00e1c t\u00edch c\u1ef1c n\u00e0o c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu CRDL trong n\u0103m 2025?","answer":"C\u00e1c ch\u1ea5t x\u00fac t\u00e1c t\u00edch c\u1ef1c bao g\u1ed3m th\u00e0nh c\u00f4ng trong th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II, ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i cho CardiolRx\u2122, s\u1ef1 l\u1ea1c quan c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 cao, v\u00e0 xu h\u01b0\u1edbng ng\u00e0nh t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb vi\u00eam tim m\u1ea1ch."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o CRDL?","answer":"B\u1ea1n n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf (2-3% danh m\u1ee5c), mua d\u1ea7n theo ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1, \u0111\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7 15-20%, v\u00e0 theo d\u00f5i s\u00e1t c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp c\u0169ng nh\u01b0 c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 giao d\u1ecbch c\u1ed5 phi\u1ebfu CRDL?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi m\u1edbi v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c phong ph\u00fa, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CRDL th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch cung c\u1ea5p c\u1ed5 phi\u1ebfu NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng uy t\u00edn, ho\u00e0n th\u00e0nh x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n ph\u00f9 h\u1ee3p."},{"question":"Cardiol Therapeutics Inc. (CRDL) c\u00f3 ph\u1ea3i l\u00e0 m\u1ed9t kho\u1ea3n \u0111\u1ea7u t\u01b0 r\u1ee7i ro cao kh\u00f4ng?","answer":"C\u00f3, CRDL l\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng v\u1edbi bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 r\u1ee7i ro li\u00ean quan \u0111\u1ebfn k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 quy tr\u00ecnh ph\u00ea duy\u1ec7t FDA. Nh\u00e0 \u0111\u1ea7u t\u01b0 n\u00ean c\u00e2n nh\u1eafc k\u1ef9 v\u00e0 ch\u1ec9 \u0111\u1ea7u t\u01b0 m\u1ed9t ph\u1ea7n nh\u1ecf danh m\u1ee5c."},{"question":"C\u00e1c ch\u1ea5t x\u00fac t\u00e1c t\u00edch c\u1ef1c n\u00e0o c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu CRDL trong n\u0103m 2025?","answer":"C\u00e1c ch\u1ea5t x\u00fac t\u00e1c t\u00edch c\u1ef1c bao g\u1ed3m th\u00e0nh c\u00f4ng trong th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n II, ch\u1ec9 \u0111\u1ecbnh thu\u1ed1c m\u1ed3 c\u00f4i cho CardiolRx\u2122, s\u1ef1 l\u1ea1c quan c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 cao, v\u00e0 xu h\u01b0\u1edbng ng\u00e0nh t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb vi\u00eam tim m\u1ea1ch."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o CRDL?","answer":"B\u1ea1n n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf (2-3% danh m\u1ee5c), mua d\u1ea7n theo ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1, \u0111\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7 15-20%, v\u00e0 theo d\u00f5i s\u00e1t c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp c\u0169ng nh\u01b0 c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 giao d\u1ecbch c\u1ed5 phi\u1ebfu CRDL?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi m\u1edbi v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c phong ph\u00fa, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T13:58:47+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)\",\"datePublished\":\"2025-08-25T13:58:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-25T13:58:47+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T13:58:47+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)","datePublished":"2025-08-25T13:58:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-25T13:58:47+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cardiol Therapeutics Inc. (CRDL)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":348129,"slug":"how-to-buy-cardiol-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Cardiol Therapeutics Inc. (CRDL) - Investimento em a\u00e7\u00f5es da Cardiol Therapeutics Inc. (CRDL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-cardiol-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/348132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=348132"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/348132\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=348132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=348132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=348132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}